Search research articles
Contact Us
Filters
Showing results (121-130 of 142) with videos related to
Page
of 15
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 27, 2017
Radiation-induced lung toxicity in non-small-cell lung cancer: Understanding the interactions of clinical factors and cytokines with the dose-toxicity relationship
Peter G Hawkins, Philip S Boonstra, Stephen T Hobson, et al.
Cancer Medicine
|
November 7, 2024
Pan-Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare System
Sean R Miller, Matthew Schipper, Lars G Fritsche, et al.
The Lancet. Oncology
|
May 31, 2024
Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health system
Alex K Bryant, Jacqueline R Lewy, R Daniel Bressler, et al.
The Lancet. Oncology
|
November 17, 2024
Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort study
Sean Miller, Ralph Jiang, Matthew Schipper, et al.
Cancer Research
|
May 19, 2019
Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy
Qiang Zhang, Michael D Green, Xueting Lang, et al.
Translational Lung Cancer Research
|
November 19, 2019
Validation of a serum 4-microRNA signature for the detection of lung cancer
Xia Yang, Wenmei Su, Xiuyuan Chen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 2, 2008
Small cell lung cancer
Gregory P Kalemkerian, Wallace Akerley, Robert J Downey, et al.
Cancer Investigation
|
November 1, 2023
Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an Alternative Platinum-Containing Regimen in 116 Patients with Early Triple Negative Breast Cancer
Ashish Singh, Josh Thomas Georgy, Anjana Joel, et al.
Cancer Research
|
July 19, 2017
Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers
Vasudha Murlidhar, Rishindra M Reddy, Shamileh Fouladdel, et al.
Cancer
|
June 10, 2024
Impact of lung cancer screening on stage migration and mortality among the national Veterans Health Administration population with lung cancer
Donna M Edwards, Mina Pirzadeh, Tony Van, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 142) with videos related to
Sort By:
Page
of 15
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 27, 2017
Radiation-induced lung toxicity in non-small-cell lung cancer: Understanding the interactions of clinical factors and cytokines with the dose-toxicity relationship
Peter G Hawkins, Philip S Boonstra, Stephen T Hobson, et al.
Cancer Medicine
|
November 7, 2024
Pan-Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare System
Sean R Miller, Matthew Schipper, Lars G Fritsche, et al.
The Lancet. Oncology
|
May 31, 2024
Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health system
Alex K Bryant, Jacqueline R Lewy, R Daniel Bressler, et al.
The Lancet. Oncology
|
November 17, 2024
Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort study
Sean Miller, Ralph Jiang, Matthew Schipper, et al.
Cancer Research
|
May 19, 2019
Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy
Qiang Zhang, Michael D Green, Xueting Lang, et al.
Translational Lung Cancer Research
|
November 19, 2019
Validation of a serum 4-microRNA signature for the detection of lung cancer
Xia Yang, Wenmei Su, Xiuyuan Chen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 2, 2008
Small cell lung cancer
Gregory P Kalemkerian, Wallace Akerley, Robert J Downey, et al.
Cancer Investigation
|
November 1, 2023
Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an Alternative Platinum-Containing Regimen in 116 Patients with Early Triple Negative Breast Cancer
Ashish Singh, Josh Thomas Georgy, Anjana Joel, et al.
Cancer Research
|
July 19, 2017
Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers
Vasudha Murlidhar, Rishindra M Reddy, Shamileh Fouladdel, et al.
Cancer
|
June 10, 2024
Impact of lung cancer screening on stage migration and mortality among the national Veterans Health Administration population with lung cancer
Donna M Edwards, Mina Pirzadeh, Tony Van, et al.
Page
of 15